Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT07278960
Eligibility Criteria:
Inclusion Criteria:
For children:
* Born as a result of an ART program (IVF, ICSI, FET, or Fresh-ET).
* Age at the time of assessment: from birth up to 36 months.
* Availability of complete perinatal and medical documentation, including ART cycle characteristics and neonatal outcomes.
* Informed consent provided by parents or legal guardians for participation in the study and for biological sample collection (where applicable).
For mothers:
* History of pregnancy achieved through ART within the territory of Kazakhstan.
* Availability of data on pharmacological treatment before and during pregnancy (e.g., hormonal therapy, antithyroid drugs, vitamins, micronutrients).
* Willingness to provide anamnestic and perinatal information, and consent for access to medical records.
For fathers (in ICSI subgroup):
* Documented infertility factor necessitating ICSI.
* Agreement to provide relevant medical history and participate in comparative analyses (e.g., endocrine or reproductive parameters of father-son pairs).
Sex:
ALL
Minimum Age:
0 Months
Maximum Age:
3 Years
Study:
NCT07278960
Study Brief:
Protocol Section:
NCT07278960